FHL1 activates myostatin signalling in skeletal muscle and promotes atrophy

FEBS Open Bio

Volumn 5, Issue , 2015, Pages 753-762

  Lee, Jen Y ^a   Lori, Dede ^a   Wells, Dominic J ^b   Kemp, Paul R ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

FHL1; Fibre type; Mouse; Muscle wasting; Myostatin

Indexed keywords

FOUR AND A HALF LIM DOMAIN PROTEIN 1; MYOSTATIN; PEPTIDES AND PROTEINS; SMAD PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPORATION; GENE EXPRESSION; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TIBIALIS ANTERIOR MUSCLE;

EID: 84942014986     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2015.08.011     Document Type: Article

References (36)

1. Swallow E.B., Reyes D., Hopkinson N.S., Man W.D., Porcher R., Cetti E.J., et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007, 62:115-120.
2. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., Boirie Y., Cederholm T., Landi F., et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010, 39(4):412-423. afq034 [pii]. 10.1093/ageing/afq034.
3. Degens H., Alway S.E. Control of muscle size during disuse, disease, and aging. Int. J. Sports Med. 2006, 27(2):94-99. 10.1055/s-2005-837571.
4. Natanek S.A., Gosker H.R., Slot I.G., Marsh G.S., Hopkinson N.S., Man W.D.-C., et al. Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (COPD); implications for stratified medicine?. Muscle Nerve 2013, 48:488-497.
5. Sullivan M.J., Green H.J., Cobb F.R. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990, 81(2):518-527.
6. Sirca A., Susec-Michieli M. Selective type II fibre muscular atrophy in patients with osteoarthritis of the hip. J. Neurol. Sci. 1980, 44(2-3):149-159.
7. Larsson L., Sjodin B., Karlsson J. Histochemical and biochemical changes in human skeletal muscle with age in sedentary males, age 22-65 years. Acta Physiol. Scand. 1978, 103(1):31-39. 10.1111/j.1748-1716.1978.tb06187.x.
8. Grobet L., Martin L.J., Poncelet D., Pirottin D., Brouwers B., Riquet J., et al. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat. Genet. 1997, 17(1):71-74. 10.1038/ng0997-71.
9. Mosher D.S., Quignon P., Bustamante C.D., Sutter N.B., Mellersh C.S., Parker H.G., et al. A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs. PLoS Genet. 2007, 3(5):e79. 10.1371/journal.pgen.0030079.
10. Hennebry A., Berry C., Siriett V., O'Callaghan P., Chau L., Watson T., et al. Myostatin regulates fiber-type composition of skeletal muscle by regulating MEF2 and MyoD gene expression. Am. J. Physiol. Cell Physiol. 2009, 296(3):C525-C534. 10.1152/ajpcell.00259.2007.
11. McPherron A.C., Lawler A.M., Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997, 387(6628):83-90.
12. Carlson C.J., Booth F.W., Gordon S.E. Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am. J. Physiol. 1999, 277(2 Pt 2):R601-R606.
13. Jespersen J.G., Nedergaard A., Andersen L.L., Schjerling P., Andersen J.L. Myostatin expression during human muscle hypertrophy and subsequent atrophy: increased myostatin with detraining. Scand J. Med. Sci. Sports 2011, 21(2):215-223. 10.1111/j.1600-0838.2009.01044.x.
14. Ding L., Wang Z., Yan J., Yang X., Liu A., Qiu W., et al. Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway. J. Clin. Invest. 2009, 119(2):349-361. 10.1172/JCI35930.
15. Cowling B.S., McGrath M.J., Nguyen M.A., Cottle D.L., Kee A.J., Brown S., et al. Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy. J. Cell Biol. 2008, 183(6):1033-1048.
16. Windpassinger C., Schoser B., Straub V., Hochmeister S., Noor A., Lohberger B., et al. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am. J. Hum. Genet. 2008, 82(1):88-99.
17. Raffaello A., Laveder P., Romualdi C., Bean C., Toniolo L., Germinario E., et al. Denervation in murine fast-twitch muscle: short-term physiological changes and temporal expression profiling. Physiol. Genomics 2006, 25(1):60-74.
18. Roth S.M., Ferrell R.E., Peters D.G., Metter E.J., Hurley B.F., Rogers M.A. Influence of age, sex, and strength training on human muscle gene expression determined by microarray. Physiol. Genomics 2002, 10(3):181-190. 10.1152/physiolgenomics.00028.2002.
19. Riddoch Contreras J., Sathyapala A., Marsh G., Polkey M.I., Kemp P. Four and a half LIM domain 1 (FHL1) is associated with activity, strength and MHC IIa expression in quadriceps of patients with chronic obstructive pulmonary disease (COPD). J. Physiol. Proceed. Physiol. Soc. 2009, 14:C3.
20. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991, 108(2):193-199.
21. Favot L., Hall S.M., Haworth S.G., Kemp P.R. Cytoplasmic YY1 is associated with increased smooth muscle-specific gene expression: implications for neonatal pulmonary hypertension. Am. J. Pathol. 2005, 167(6):1497-1509. 167/6/1497 [pii].
22. Dennler S., Itoh S., Vivien D., ten Dijke P., Huet S., Gauthier J.M. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 1998, 17(11):3091-3100. 10.1093/emboj/17.11.3091.
23. Bloch S., Lee J.Y., Wort S.J., Polkey M.I., Kemp P., Griffiths M. Sustained elevation of circulating GDF-15 and a dynamic imbalance in mediators of muscle homeostasis are associated with the development of acute muscle wasting following cardiac surgery. Crit. Care Med. 2013, 41:982-989.
24. Okabe M., Ikawa M., Kominami K., Nakanishi T., Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 1997, 407(3):313-319. doi:S0014-5793(97)00313-X.
25. Brown D.M., Parr T., Brameld J.M. Myosin heavy chain mRNA isoforms are expressed in two distinct cohorts during C2C12 myogenesis. J. Muscle Res. Cell Motil. 2012, 32(6):383-390. 10.1007/s10974-011-9267-4.
26. Dedieu S., Mazeres G., Cottin P., Brustis J.J. Involvement of myogenic regulator factors during fusion in the cell line C2C12. Int. J. Dev. Biol. 2002, 46(2):235-241.
27. Gollins H., McMahon J., Wells K.E., Wells D.J. High-efficiency plasmid gene transfer into dystrophic muscle. Gene Ther. 2003, 10(6):504-512. 10.1038/sj.gt.3301927.
28. McMahon J.M., Signori E., Wells K.E., Fazio V.M., Wells D.J. Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase - increased expression with reduced muscle damage. Gene Ther. 2001, 8(16):1264-1270. 10.1038/sj.gt.3301522.
29. Gregorevic P., Meznarich N.A., Blankinship M.J., Crawford R.W., Chamberlain J.S. Fluorophore-labeled myosin-specific antibodies simplify muscle-fiber phenotyping. Muscle Nerve 2008, 37(1):104-106. 10.1002/mus.20877.
30. Ellis P.D., Smith C.W., Kemp P. Regulated tissue-specific alternative splicing of enhanced green fluorescent protein transgenes conferred by alpha-tropomyosin regulatory elements in transgenic mice. J. Biol. Chem. 2004, 279(35):36660-36669.
31. Lee J.Y., Hopkinson N.S., Kemp P.R. Myostatin induces autophagy in skeletal muscle in vitro. Biochem. Biophys. Res. Commun. 2011, 415(4):632-636. 10.1016/j.bbrc.2011.10.124.
32. Durieux A.C., Amirouche A., Banzet S., Koulmann N., Bonnefoy R., Pasdeloup M., et al. Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression. Endocrinology 2007, 148(7):3140-3147. 10.1210/en.2006-1500.
33. Zhang D., Liu M., Ding F., Gu X. Expression of myostatin RNA transcript and protein in gastrocnemius muscle of rats after sciatic nerve resection. J. Muscle Res. Cell Motil. 2006, 27(1):37-44. 10.1007/s10974-005-9050-5.
34. Plant P.J., Brooks D., Faughnan M., Bayley T., Bain J., Singer L., et al. Cellular markers of muscle atrophy in chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 2010, 42(4):461-471. 10.1165/rcmb.2008-0382OC.
35. McFarlane C., Plummer E., Thomas M., Hennebry A., Ashby M., Ling N., et al. Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism. J. Cell. Physiol. 2006, 209(2):501-514. 10.1002/jcp.20757.
36. Reisz-Porszasz S., Bhasin S., Artaza J.N., Shen R., Sinha-Hikim I., Hogue A., et al. Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am. J. Physiol. Endocrinol. Metab. 2003, 285(4):E876-E888. 10.1152/ajpendo.00107.2003.